Mayet Petines-Pantastico

Maccine is a Singapore-based preclinical contract research organization providing innovative discovery research and quality safety-assessment services to the global biotechnology and pharmaceutical industry. It offers creating translational value in the preclinical research space and significant investment in technology, people and science has ensured Maccine's position at the forefront of global preclinical research. Maccine is an established preclinical contract research organization providing innovative discovery support and regulatory safety assessment services. Operating on a collaborative partnering model, Maccine has developed a portfolio of in vivo assays in key therapeutic areas including Neurology, Psychiatry, Metabolic Disorders, Pain & Inflammation, Oncology, Musculoskeletal Disorders and Women's Health. Naturalistic models, clinical biomarkers and clinical technology platforms are employed to better represent the clinical disease state. The team is supported by significant investment in high-end technology and access to a world class scientific community.

Marken Ltd. provides clinical trial logistics solutions to the life sciences industry. Its services include depot, supply chain logistics and value added services such as global project management, medical device delivery, clinical trial logistics and regulatory, customs consultancy, and drug product shipments. The company was founded in 1980 and is headquartered in London, the United Kingdom.

United Laboratories, Inc. develops and manufactures prescription and consumer health products. Its products include Alaxan FR, Biogesic, Ceelin, Dolfenal 250mg, Eneryon and Myra e. The company was founded by Jose Y. Campos and Mariano K. Tan in 1945 and is headquartered in Mandaluyong, Philippines.

Part of DKSH Holding AG, DKSH Australia Pty Ltd. is an Australian company that supplies chemicals and ingredients for food, pharmaceutical, personal care, and various industrial applications. The company is based in Hallam, Australia.

vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia.